Bone drugs may have addedbenefit: Lower pneumonia risk
By Nicholas Bakalar
Osteoporosis drugs such as Fosamax and Actonel may have an additional benefit: A new study suggests they are associated with a reduced risk for pneumonia.
Researchers studied the nitrogen-containing bisphosphonates, prescription drugs sold under various brand names for the treatment of osteoporosis. Using a database of patients 50 and older hospitalized for hip fracture, the scientists compared 4,041 people who used bisphosphonates with 11,802 who were not exposed to the drugs.